Page 3 - ம்ட்கஷ ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ம்ட்கஷ ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ம்ட்கஷ ஆரோக்கியம் Today - Breaking & Trending Today

Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic


Liquid Biopsy Markets, 2025 with Impact of COVID-19 Pandemic
February 02, 2021 04:43 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring.
The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the impact of the COVID pandemic on the Liquid Biopsy market? This report provides a detailed analysis.
Circulating Tumor Cells? Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and t ....

Miltenyi Biotec , Siemens Healthineers , Qiagen Gmbh , Sysmex Inostics , Laura Wood , Academic Research Lab , Testing Lab , Public National , Central Lab , Technology Development , Singlera Genomics Inc , Physician Lab , Physician Office Lab , M Liquid Biopsy Initiative , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd , Bioneer Corporation , Genomics Co , Big Picture On Liquid Biopsy Technology , Thermo Fisher Scientific Inc ,

Global Immuno-Oncology Diagnostics Markets, 2021-2025: Checkpoint Assays, Cytokine Assays, Genomic Germline, Genomic Tumour, Tumor Microenviroment


4.3.2 Shifting Role of Diagnostics
4.3.3 Multiplexing and Foundation One
4.3.4 The Disruption Dynamic
4.3.6 The Next Five Years
5. Cancer Immuno-Oncology Diagnostics Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Qiagen Expands Immuno-Oncology Portfolio
IncellDx Awarded PD-L1 Detection Patent
FDA Approves CDx for Trastuzumab
Promega Nabs CE Mark for Microsatellite Instability IVD
ArcherDx partners with AstraZeneca for Immuno-Oncology
Germline Results Guides Precision Therapy
Agilent PD-L1 Assay Gets FDA Approval
Bayer, OrigiMed Form Companion Diagnostic Development Alliance
Bio-Me to Develop Microbiome Biomarker Test for Cancer Immunotherapy
SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological ....

Agena Bioscience , Nugenerex Immuno , Dako Agilent , Clearbridge Biomedics , Bristol Myers Squibb , Leica Biosystems , Laura Wood , Foundation Medicine , Academic Research Lab , Guardant Health , Testing Lab , Public National , Technology Development , Thermo Fisher , Origimed Form Companion Diagnostic Development Alliance , Merck Co Inc , Cytolumina Technologies Corp , Physician Lab , Beckman Coulter , Epic Sciences , Mdx Health , Custom Research , Genomic Health , Office Hours Call , Becton Dickinson , Biodesix Inc ,

World Human Gene Sequencing Markets, 2021-2025 - The COVID-19 Pandemic has Put the Market on Pause


4.1 Recent Developments - Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
Genetron Health Targeting Early Cancer Detection
Pan-European Initiative to Build Tools for Sharing Genomic Data
UK Government Unveils New Genomic Healthcare Strategy
Foundation Medicine Liquid Biopsy Gets FDA Approval
American Heart Association Develops Genetic Testing Guidelines
Yourgene Health Gets CE Mark for Iona NIPT Test
NorthShore Looks to Expand Genomics Integration Into Primary Care
Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients
FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
BillionToOne Closes $15M Series A Follow-on Round ....

United States , United Kingdom , Qiagen Gmbh , Akonni Biosystems , Excellerate Bioscience , Pacific Biosciences , Sysmex Inostics , Omega Bioservices , Siemens Healthineers , Laura Wood , Profiles Of Key Companies , Me Inc , Public National , Ge Healthcare Life Sciences , A Research Bonanza , Genomics Personalized Health , Pathgroup Enter Co , Singlera Genomics Inc , American Heart Association Develops Genetic Testing Guidelines , Invitae Corporation , Ge Global Research , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Genetic Screening Test For Proactive Health Management , Fluidigm Corp ,

World Whole Genome and Exome Sequencing Markets, 2021-2025: COVID-19 Drives Overnight Global Growth in Pathogen Sequencing


World Whole Genome and Exome Sequencing Markets, 2021-2025: COVID-19 Drives Overnight Global Growth in Pathogen Sequencing - A New Industry Emerges.
December 16, 2020 10:43 ET
| Source:
Research and Markets
Research and Markets
Dublin, IRELAND
ResearchAndMarkets.com s offering.
The COVID Pandemic has created a surge in Whole Genome Sequencing of Pathogens but cancer-related activity has suffered. Find out all about it in the comprehensive report of Whole Genome Sequencing. The complete genome of the COVID virus is included as an example of the work being done.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What s holding the industry back? Where are the over 800 locations that have high throughput devices? ....

New York , United States , United Kingdom , Oxford Nanopore , Pacific Biosystems , Qiagen Gmbh , Akonni Biosystems , Excellerate Bioscience , Sysmex Inostics , Omega Bioservices , Siemens Healthineers , Laura Wood , Microfluidic Sanger , Profiles Of Key Companies , Invitae Acquires Three Companies , Me Inc , Public National , Ge Healthcare Life Sciences , Discovery Life Sciences Enter , Genomics Personalized Health , Service Suppliers , Singlera Genomics Inc , Genomic Medicine Lab , Invitae Corporation , Fertility Technology Comes Of Age , Ge Global Research ,